<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02733835</url>
  </required_header>
  <id_info>
    <org_study_id>CIRB/2015/2352</org_study_id>
    <nct_id>NCT02733835</nct_id>
  </id_info>
  <brief_title>VPIA Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration</brief_title>
  <official_title>Novel Vital-sign Patient-assisted Intravenous Analgesia With Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration: a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KK Women's and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KK Women's and Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective cohort study aiming to evaluate an improved VPIA remifentanil
      algorithm which would benefit labouring mothers who are unable or unwilling to receive
      epidural analgesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study trials a new Vital signs-controlled patient-assisted intravenous analgesia (VPIA)
      regimen using a purpose-built pump that aims to enhance the efficacy, safety and
      personalization of remifentanil therapy for labouring women. The system studies the
      parturient's pattern of analgesic use in 15 minute epochs and titrates the demand doses and
      basal infusion rate to maintain a plasma level of remifentanil that is appropriate for the
      degree of pain felt.

      The system incorporates vital signs (pulse oximetry and heart rate values) into the algorithm
      which would temporarily stop the pump and step down doses accordingly when predefined
      critical values are reached.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal desaturation</measure>
    <time_frame>Duration of labour</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maternal bradycardia</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Apnoea/hypopnoea</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Side effects: pruritus</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
    <description>Pruritus</description>
  </other_outcome>
  <other_outcome>
    <measure>Side effects: nausea vomiting</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
    <description>Nausea/vomiting</description>
  </other_outcome>
  <other_outcome>
    <measure>Side effects: sedation</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
    <description>Sedation</description>
  </other_outcome>
  <other_outcome>
    <measure>Maternal outcomes: duration of labour</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
    <description>Duration of labour (minutes)</description>
  </other_outcome>
  <other_outcome>
    <measure>Maternal outcomes: duration of second stage</measure>
    <time_frame>At delivery, an expected average of 1 hour</time_frame>
    <description>Duration of second stage (minutes)</description>
  </other_outcome>
  <other_outcome>
    <measure>Maternal outcomes: pain score</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
    <description>Maternal pain score (out of 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>Maternal outcomes: satisfaction score</measure>
    <time_frame>Duration of labour, an expected average of 24 hours</time_frame>
    <description>Maternal satisfaction score (%)</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal outcomes: birth weight</measure>
    <time_frame>Immediately after birth</time_frame>
    <description>Birth weight in grams</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal outcomes: APGAR</measure>
    <time_frame>Immediately after birth</time_frame>
    <description>APGAR scores</description>
  </other_outcome>
  <other_outcome>
    <measure>Neonatal outcomes: cord blood pH</measure>
    <time_frame>Immediately after birth</time_frame>
    <description>Umbilical cord blood pH</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Remifentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remifentanil Patient Controlled Analgesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>Vital signs-controlled, patient assisted intravenous analgesia using remifentanil</description>
    <arm_group_label>Remifentanil</arm_group_label>
    <other_name>Ultiva</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who choose to use parenteral opioid for pain relief with informed consent

          -  Patients who refuse labour epidural analgesia or with contraindication to epidural
             analgesia (eg. thrombocytopaenia, previous thoraco-lumbar spinal instrumentation)

          -  Gestational age of &gt;= 36 weeks

        Exclusion Criteria:

          -  Patients who are unable to understand instructions given regarding the use of patient
             controlled analgesia (PCA) or unable to self administer PCA boluses

          -  Patients with difficulty in communication due to language differences

          -  Patients with known hypersensitivity to remifentanil or any component of its
             formulation or to other fentanyl analogue

          -  Patients with severe respiratory disease

          -  Patients with history of drug dependence of recreational drug abuse

          -  Patients with unmanaged foetal bradycardia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wan Ling Leong, MBBS FANZCA</last_name>
    <role>Principal Investigator</role>
    <affiliation>KK Women's and Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wan Ling Leong, MBBS FANZCA</last_name>
    <phone>+6563941081</phone>
    <email>leong.wan.ling@singhealth.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ban Leong Sng, MBBS FANZCA</last_name>
    <phone>+6563941081</phone>
    <email>sng.ban.leong@singhealth.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KK Women's and Children's Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>229899</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wan Ling Leong, MBBS FANZCA</last_name>
      <phone>+6563941081</phone>
      <email>leong.wan.ling@singhealth.com.sg</email>
    </contact>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <last_update_submitted>February 5, 2017</last_update_submitted>
  <last_update_submitted_qc>February 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

